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hypothesis that contact sensitivity in guinea pigs is mediated 
by T cells and their products, inflammatory lymphokines. 
These mediators could be induced in detectable amounts from 
an expanded population of hapten-specific T cells. 
Thus, our experiments suggest similarity if not identity in the 
eliciting mechanisms of contact sensitivity and tuberculin-like 
DTH to protein antigens. This view is further supported by the 
fact that antilymphokine antibodies are capable of inhibiting 
both contact sensitivity reactions to hap tens and DTH reactions 
to proteins [17). 
Clones of hapten-specific T cells should be useful for a better 
understanding of the eliciting mechanisms of contact sensitivity. 
The excellent technical assistance by Mrs. V. Weiss and Miss A. 
Stierlin, and the skillful secretarial help of Miss M. Jenni and Miss E. 
Moll is gratefully acknowledged. 
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An immune reaction to wheat protein has been previ-
ously proposed to explain the pathogenesis of dermatitis 
h e rpetiformis. In order to detect and characterize anti-
bodies to gluten in human sera, we developed an enzyme 
immunoassay for class-specific antibodies. Results of 
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this assay in 49 patients with dermatitis herpetiformis 
were compared with those of 38 normal control subjects, 
11 patients with celiac disease, and 6 small-bowel bypass 
patients. IgA antibodies to gluten were significantly 
more frequent in dermatitis herpetiformis sera (28/49) 
than in normal control sera (4/38). lgG antibodies to 
gluten were significantly more frequent in both celiac 
disease (10/11) and dermatitis herpetiformis (16/49) sera 
than in control (5/38) sera. Dermatitis herpetiformis sera 
also had an increased prevalence of lgM antibodies to 
gluten (19/49). Small-bowel bypass patients demon-
strated no antibody to gluten. Antibodies to gluten in 
dermatitis herpetiformis objectively mark a state of im-
mune reactivity to wheat protein and may be involved 
in the genesis of the cutaneous lgA immune deposits and 
the skin disease. 
Dermatitis herpetiformis (DH) is a chronic pruritic skin 
condition characterized by subepidermal blister formation and 
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granular IgA deposits in the skin [1]. Greater than 70% of DH 
patients show small-bowel villous atrophy similar to t hat seen 
in celiac clisease (glute n-se nsitive enteropath y ) [1,2). In DH the 
small-bowel injill'y is less sever e than in celiac disease (CD) , 
and gastrointestinal symptoms a r e u sually mild or a bsent. DH 
patients may h ave serum antibodies to wheat protein, but these 
antibodies h ave only rarely bee n of the IgA class (3- 5). In view 
of the IgA deposits in the skin, the recent demonstra t ion of 
gluten bincling to the site of IgA depsoits [6], a nd the evide n ce 
for circulat ing IgA immune complexes in DH [7,8], we have 
reexamined by an improved enzyme immunoassay (EIA) , sera 
from DH patients for class-specific a n tibodies to gluten . 
MATERIALS AND METHODS 
Study Subjects 
For this study, sera were collected from 104 individuals wi thout 
regard to dietary wheat protein intake. Sera were coded and frozen at 
-70 °C in sma ll aliquots. Control sera were collected from 38 healthy 
adults with no skin or bowel disease (mean age 30 years). Sera were 
ob t ained fro m 49 DH patients (mean age 46 years) in whom the 
cliagnosis of DH had been confirmed by immunofluorescence. At the 
t ime of t he study, none of the DH patients was on a strict glu ten-fTee 
cliet but they were being treated with sulfapyridine or dapsone. Sera 
from 11 CD patients (mean age 10 years) were also evaluated. Each 
CD patien t had symptomatic bowel disease related to wheat protein 
ingestion a nd villous atrophy documented by small-bowel biopsy. Six 
patie nts who had unde1·gone small-bowel bypass surgery (SBB) (mean 
age 32.5 years) served as a bowel disease control group. These patients 
ha d no skin disease but demonstrated elevated circulating IgA immune 
complexes by Raji ce ll assay [7]. 
Wheat Protein Antigen 
Commercia l grade wheat protein glu ten (Sigma, St. Louis, Missouri) 
was mixed in 0.1 M carbonate buffer, pH 9.6, for 2 h at room temperature 
and t hen incubated at 4°C for 18 h. The solution was then centri fuged 
at 2,200 g for 10 min and the supem atant was separated. The super-
natan t was passed t l1l'ough a 0.2-/lm fil ter (Nalge, Rochester, New 
York) and was stored in a sterile container at 4°C. The protein concen-
tration of the solu tion was measured by the dye-binding method (Bio-
Rad, Richmond, California) and was defined as the glu ten concentration 
[9]. 
Enzyme Immunoassay 
The EIA was adapted from that of Huff et al [5] with the following 
improvements. The wells of the polystyrene microtiter plate were 
incubated with 0.1% glu teraldehyde prior to addit ion of the glu ten 
a n t igen. The glu ten ant igen was more efficiently bound to the glu ter-
aldeh yde-activated wells. AU sera were dilu ted in borate-buffered saline 
(BBS) with 0.05% Tween-20 because of the longer shelf life of this 
bacteriostatic buffer [10]. As a color substrate for peroxidase, a hydro-
gen peroxide-4-aminoantipyrine solu tion [11] was used instead of the 
color substrate containing 5-aminosalicylic acid. This reagent is color-
less and stable with storage and produces a soluble red reaction product 
in the p1·esence of peroxidase. This colored product is easily visualized 
and quantitated with a spectrophotometer. Finally, the quantitation of 
the E IA was greatly facilitated by the use of an 8-channel photometer 
capable of reading and record ing optical densities in all 96 wells of a 
microtiter plate in less than 60 s (Titertek Multiskan, Flow Laborato-
ries, M cLean, Virginia). 
The following EIA was used for these studies: 100 Ill of 0.1% glu ter-
aldehyde in 0.1 M ca1·bonate buffer, pH 9.6, was added to each well of 
th e 96-well polystyrene microtiter plate (Limbro, Flow Laboratories). 
T h e plate was incubated 2 h at 37°C, emptied, and washed 3 times with 
distilled water. One hundred microli ters of glu ten solu tion in 0.1 M 
carbonate buffer, pH 9.6, was added to each well. After incubation for 
18 h at 4 °C, wells were emptied a nd washed 3 times with 0.05 M BBS, 
pH 8 .0, with 0.05% Tween-20. Human sera to be tested were dilu ted in 
BBS, and 100 Ill was added to each well. Plates were incubated 90 min 
at 37 °C, emptied, and washed 3 times with BBS. Monospecific goat 
antibodies conjugated wi th horseradish peroxidase (Miles, Elkhar t, 
lncliana) were dilu ted in BBS, and 100 Il l of the dilu ted conjugate was 
added to each well. Wells containing the conjugate solutions were 
incubated 60 min at 37°C, emptied, and then washed 3 times with BBS. 
One hundred microli te rs of the hyd1·ogen peroxide-4-aminoantipyr ine 
color solu tion was added to each well [11]. After 1 h of incubation at 
37°C, opt ical densities of each well were measured on the 8-channel 
photometer with a 492-nm filter . 
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Dilutions 
Checkerboard titrations of reagents at each step of the procedure 
were performed in the establishment of this assay. Sera known to be 
posit ive for ant ibodies to glu ten were used for these titrations. The 
dilu tions of reagents chosen for the fin al assay were those that produced 
optimal positive results with positive sera and minimized the back-
ground with negative sera. The optimal glu ten antigen concentration 
was 140 /lg/ ml. The optimal dilu t ions of sera were 1:25 for IgA and IgM 
antibody determinations and 1:100 for IgG antibody determinations. 
The optimal horseradish peroxidase conjugate di.lu tions were 1:200 for 
IgA and IgM and 1:400 for IgG. 
Statistical Evaluation 
DW'ing the development of these assays, multiple replicate samples 
were evaluated. The SD of optical densities of samples on the same 
plate was consistently less than 4% of the mean value for the replicate 
samples. Reproducibility of the assay was evaluated by repeated assays 
of the same 23 samples on 6 separate occasions. T he day-to-day 
variance for repeated testing was 3% for IgA, 10% for IgG, and 7% for 
IgM. 
For the final data, all sera were tested on a single occasion. Tests for 
IgG, lgA, and lgM an tibodies were performed on separate microtiter 
plates. Because of the reproducibility of the assay, a single well on each 
plate was used for each serum. A panel of 22 normal control sera was 
placed on each plate and all resul ts on a plate were compru·ed to thi 
panel. The mean optical density and SD of the normal control panel 
was calculated for each plate. 
Hesul ts for each serum were expressed as SD a bove or below the 
mean of the control panel. Sera with optical densities 2 or more SD 
above that of the panel were defined as posit ive for antibodies to glu ten. 
The frequency of positive sera in patients with DH, CD, and SBB was 
compared with that of 38 normal contro ls by Fisher's Exact Test. 
Probabili t ies less than .05 were considered significant. 
RESULTS 
The r esults of the assays for lgG, IgA, and IgM antibodies to 
gluten are illustrated in Figs 1, 2, and 3, r espectively. The 
frequen cy of positive tests for IgG a n tibodies to glute n was 
significantly higher t han con trols for both DH a nd CD sera but 
was most significan t for CD sera (Ta ble I). The freq u en cy of 
P?Sitive tests for IgA a n tibodies to gluten was s ignificantly 
higher for DH (28/49) a nd of borderline significance for CD. 
Positive tests for IgM a n t ibodies were significan t only for DH 
sera. N o gluten a ntibodies wer e de tected in SBB sera. 
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FIG l. lgG antibodies to glu ten. Each closed circle represents the 
SD of the optical density of a n individual serum from the mean optical 
density of the 22 control sera. Values above the line at 2 SD ru·e 
considered positive. 
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FIG 3. lgM antibod ies to glu ten. Each closed circle represents the 
SO of the optical density of an individual serum from the mean optical 
density of the 22 control sera. Valu es a bove the Lin.e at 2 SD are 
conside red positive. 
DISCUSSION 
This study confirms that DH and CD patients demonstrate 
immune reactivity to wheat protein a nd suggests that a nti-
bodies to gluten in DH patients a1·e predominantly of the l gA 
class. However, the differences between DH and CD are not 
clear-cut. Individual sera with the largest amounts of IgG 
antibodies to gluten and ones with the largest amounts of IgA 
antibodies to gluten, as reflected by optical densities (Figs 1, 2), 
were CD sera. Nevertheless, IgG antibodies to glu ten were more 
frequent in CD (10/11) th an in DH (16/49), and IgA antibodies 
to glu ten were more characteristic of DH (28/49) than CD (4/ 
11). Although the CD patients had no skin disease, the 4 CD 
patients with large amounts of l gA antibody to gluten might 
have had subclinical DH. Skin immunofluorescence was not 
performed on CD patients to rule out this possibility. Clinically, 
Vol. 80, No.5 
these 4 CD patien ts were no different from the oth er CD 
patients. Other possible explanations are that factors other than 
lgA a ntibodies to gluten are important in the pathogenesis of 
DH and th at patients with lru:ge amounts of lgA antibodies to 
gluten do not develop soluble circulating immune complexes in 
antigen excess. The explanation of the frequently positive test 
for l gM antibodies to gluten in DH sera is unknown. The 
immune deposits in the skin of DH patients do not us ually 
contain IgM. Perhaps with the less severe bowel dam age in DH 
than in CD , DH patients tend to overproduce secretory anti-
bodies to gluten of both the l gA and IgM classes. Results in the 
bowel disease control group, SBB patients, who demonstrated 
circulating immune complexes con taining l gA, suggest t h at 
antibodies to glu ten are not simply secondary to th e presence 
of bowel disease and a1·e not nonspecific markers of malabsorp-
tion. The small amount of overlap between DH a nd CD and 
the nmmal controls likely reflects h eterogeneity in each grou p 
and the small amount of variability inna te in a multistep assay 
such as EIA. Another possibility is that immune reactivity to 
wheat protein may exist at a low frequency in normal individ-
uals. 
The ability to detect class-specific antibodies to wheat protein 
is dependent on the sensitivity of the assay employed. Others 
have de tected gluten antibodies of the IgG class in as high as 
18% of DH patients by immunodiffusion (12] and immunofluo-
rescence (3]. Menzel et al were able to detect IgA antibodies to 
gluten in 3/21 DH patients by a radioimmunoassay technique 
[ 4]. In our previous studies with an EIA, we detected l gG 
antibodies to gluten in 5/ 14 DH patients but were unable to 
identify lgA antibodies to glu ten in these patients [5]. The 
improved sensitivity of this "second generation" EIA that we 
employed in the current study is attributable to the improved 
techniques described above and the commercial availability of 
high-quality enzyme-conjugated monospecific antibodies to hu-
man immunoglobulin classes. 
Any scheme proposed for the pathogenesis of DH must 
consider two well-documented facts. First, granular lgA depos-
its are found in the skin of all DH patients and presumably are 
involved in the pathogenesis of the skin disease (1]. Secondly, 
a gluten-sensitive enteropathy, usually asymptomatic, can be 
found in most patients with DH, and both bowel and skin 
disease may respond to a strict gluten-free diet [1 ,2]. A patho-
genetic mechanism for DH involving circulating immune com-
plexes containing wheat protein a nd IgA antibodies has been 
hypothesized to explain these facts. In support of this hypoth-
esis, circulating immune complexes containing IgA, identified 
by the Raji cell technique, have been reported by Zone et al (7] 
a nd Hall et al (8]. Fwthermore, Zone et al have detected 
evidence of wheat protein a nt igen in these cil·culating complexes 
(13], and in our previous studies we have been a ble to detect 
cil·culating gluten in DH sera (14]. Recently, the binding of 
wheat protein at the site of IgA deposition in the skin has been 
reported (6]. The circulating immune complex mechanism for 
DH implies that IgA a ntibodies to wheat protein are present in 
DH patients. This study confirms the presence of such anti-
TA I3LE I. Positive tests for class-specific antibodies to gluten 
IgG l gA l gM 
Antibodies Antibodies Antibodies 
Normal Controls 
n = 38 5 (13%) 4 (11%) 1 (3%) 
DH 
n = 49 16 (33%) 28 (57%) 19 (39%) 
(p = 0.046)" (p = 1 X 10-")" (p = 7 X 10- 5) " 
CD 
n = 11 10 (91 %) 4 (36%) 2 (18%) 
(p = 6 X 10-0)" (p = 0.059)" (p = 0.167)" 
SBB 
n =6 0 (0%) 0 (%) 0 (0%) 
"Compared to normal controls by 2-tailed Fisher's Exact Test. 
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bodies in 57% of DH patients, and supports t he hypothesis that 
these a ntibodies m ay be involved in the genesis of the immune 
deposits in th e skin. If IgA antibodies to glu ten are a critical 
link in the pathogenesis of DH, th ey would be expected to be 
present in all DH patients. The DH patients who were negative 
for IgA antibodies to gluten in this study were clinically no 
different from those who were positive. Perhaps, th e negative 
results in som e of the DH patients might be due to th e binding 
of these a n tibodies into immune complexes. The detection of 
IgA a ntibodies to gluten in the sera of DH patients may provide 
a nother valuable clue to the pathogenesis of this disease. 
The authors thank David Lawellin, Ph.D., of the Department of 
Microbiology and Immunology, University of Colorado School of Med-
icine, for his assistance in the development of this enzyme immunoas-
say. 
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Histiocytosis X Cells in Eosinophilic Granuloma Express Ia and T6 
Antigens 
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Morphologic similarities between histiocytosis X (HX) 
cells and epidermal Langerhans cells (LC) have led to 
the hypothesis that HX represents a proliferative disor-
der of LC. In order to prove the validity of thi s assump-
tion, we tested single cell suspensions isolated from an 
eosinophilic granuloma type HX lesion for the presence 
of various antigenic d eterminants defined by monoclonal 
antibodies using an immunoelectron microscopic tech-
nique. An anti-Ia reagent reacted with essentially all 
histiocytic cells and a small portion of lymphocytes 
whereas plasma cells and eosinophils were n egative. T6 
antigen, in contrast, was disclosed exclusively on HX 
cells either with or without Birbeck granules. Pan-T ce11-
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reagent OKT3 reacted only with small lymphocytes. The 
finding that HX cells from eosinophilic granuloma le-
sions are the only cells that have the identical surface 
m arker e quipment as epidermal LC (la antigens, T6 an-
tigen, Fc-IgG, and C3 receptors) strongly supports the 
concept that these cells are derived from the LC lineage. 
In 1953, Lichtenstein [1] coined th e term "histiocytosis X " 
(HX) by combining three entities, i.e., Letterer-Siwe disease, 
Hand-Schi.iller-Christian disease, and eosinophilic granuloma 
of bone. The reason for this reclassification was that he felt 
these 3 condi tions ·r epresented varieties in degree, stage of 
involvement, and localization of the same basic disease process. 
Since that time, much work has been done to elucidate the 
histogenesis of this proliferative disorder. In 1965, Basset and 
Turiaf [2] found that a certain percentage of cells comprising 
HX lesions contained peculiar rod-shaped cytoplasmic struc-
tm es which were soon recognized as indistinguishable from 
Bu·beck granules [3,4], a chamcteristic feature of epidermal 
Langerhans cells (LC). T h e finding that Birbeck granules were 
detected in pulmonary, osseous, and cutaneous lesions of pa-
